Testing a new injection for safety in healthy adults
This trial tests a new drug called QLS2312, given as an injection, to see if it is safe and how the body handles it. It is an early study in healthy volunteers that helps decide if the drug can be studied in people with certain conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- You must weigh at least 50 kg (about 110 lbs) for men or 45 kg (about 99 lbs) for women, and your body mass index (BMI) must be between 18.5 and 28.0.
- Your blood levels of immune proteins (IgA, IgG, IgM) must be within the normal range.
- You must be in good general health, with no significant medical problems, and have normal test results or only minor abnormalities that are not medically important.
- You must agree to use effective birth control and not donate sperm or eggs during the study and for 3 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called QLS7305, given as a shot under the skin, in healthy volunteers. The purpose is to see if it is safe and how the body handles it.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
This study tests a new injection (QLS2404) in two groups: healthy volunteers and people with certain autoimmune diseases like lupus or Sjögren's syndrome. The goal is to see if the treatment is safe and how it affects the body, which could lead to new options for managing these conditions.
This study tests a new investigational drug called ISH0613 in healthy volunteers to see if it is safe and how the body processes it. It is the first time this drug is given to humans.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
Hear when a new Healthy Participants Study trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.